Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 6;9(2):ofab566.
doi: 10.1093/ofid/ofab566. eCollection 2022 Feb.

Coronavirus Disease 2019-Associated Mucormycosis in France: A Rare but Deadly Complication

François Danion  1   2 , Valérie Letscher-Bru  3 , Juliette Guitard  4 , Karine Sitbon  5 , Sarah Dellière  6 , Adela Angoulvant  7   8 , Guillaume Desoubeaux  9 , Francoise Botterel  10 , Anne-Pauline Bellanger  11 , Gilles Gargala  12 , Fabrice Uhel  13 , Marie-Elisabeth Bougnoux  14 , Victor Gerber  15 , Justin Michel  16 , Marjorie Cornu  17   18 , Stéphane Bretagne  5   6 , Fanny Lanternier  5   19 ; COVID-Mucor study group
Collaborators, Affiliations

Coronavirus Disease 2019-Associated Mucormycosis in France: A Rare but Deadly Complication

François Danion et al. Open Forum Infect Dis. .

Abstract

We studied COVID-19 associated mucormycosis based on 17 cases reported nationwide and assessed the differences with India. They differed by frequencies of diabetes mellitus (47% in France versus up to 95% in India), hematological malignancies (35% versus 1%), anatomical sites (12% versus >80% rhino-orbito-cerebral) and prognosis (88% mortality versus <50%).

Keywords: CAM; CAPA; COVID-19; mucormycosis.

PubMed Disclaimer

References

    1. Koehler P, Bassetti M, Chakrabarti A, et al. . Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis 2021; 21:e149–62. - PMC - PubMed
    1. Rudramurthy SM, Hoenigl M, Meis JF, et al. ; ECMM and ISHAM. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries. Mycoses 2021; 64:1028–37. - PMC - PubMed
    1. Buil JB, van Zanten ARH, Bentvelsen RG, et al. . Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021. Eurosurveillance 2021; 26:2100510. - PMC - PubMed
    1. Hoenigl M, Seidel D, Carvalho A, et al. . The Emergence of COVID-19 Associated Mucormycosis: Analysis of Cases From 18 Countries. Rochester, NY: Social Science Research Network. Available at: https://papers.ssrn.com/abstract=3844587. Accessed 22 June 2021.
    1. Donnelly JP, Chen SC, Kauffman CA, et al. . Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis 2020; 71:1367–76. - PMC - PubMed